Refixia 3000 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
7680662160040
CH-66216
Pulver
Associated product:
REFIXIA subst sèche 3000 UI c solv flac
1 / 3
google
Article details
- Package size
- -
- Selling units
- unbekannt
- Measure
- (1 Durchstechflasche mit Pulver und 1 Fertigspritze mit Lösungsmittel) und Verabreichungsset
- Galenic form
- Pulver
- Galenic group
- Lösbar zur Einnahme
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SOLV
|
- | Substance | HNIDK |
|
PRC
|
3000.0 UI | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
PRC
|
10.0 MG | Substance | HBESI |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HBESI |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
0.972 MGML | Substance | HBESI |
Reimbursement information
Public price
CHF 5516.05
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2024
Authorization holder
Novo Nordisk Pharma AG
8302 Kloten
Authorization information
- Swissmedic authorization number
- 66216
- Drug name
- Refixia, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
- Galenic form
- PULMJ
- ATC Code
- B02BD04
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 05/09/2017
- Authorization expiration date
- 31/12/9999
- IT Number
- 06.01.1.
- Domain
- Human medicine
Package details
- Description (FR)
- REFIXIA subst sèche 3000 UI c solv flac
- Description (DE)
- REFIXIA Trockensub 3000 IE c Solv Durchstf
- Market launch
- 19/12/2023
- Narcotic (BTM)
- No